Switzerland· 65620001
Cotellic
A cobimetinib product containing cobimetinibum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Cobimetinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01EE02 (cobimetinib), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Cobimetinib · ATC L01EE02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cobimetinib costs, country by country.
Normalised to the WHO defined daily dose (45 mg), so markets compare like for like.
- Switzerland: $221.52 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Cobimetinib · price per daily dose (45 mg)
USD · FX 28 Sept 2026
- CH Switzerland$221.52
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- cobimetinibum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L01EE02
- ATC class
- Cobimetinib
- Defined daily dose
- 45 mg, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768065620001163 StkCHF 4960.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
287 interactions on record for cobimetinib.
Graded by severity as the source publishes them — 110 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cobimetinib · interactions on record
287 records
- 110 severe
- 177 moderate
Most severe, free to view
- AprepitantA04AD12severe
- LonafarnibA16AX20severe
- BerotralstatB06AC06severe
- VoxelotorB06AX03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cobimetinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCOTELLIC 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULARoche Registration Gmbh
- NorwayCotellicAbacus Medicine A/S
- United StatesCotellicGenentech, Inc.
- FranceCOTELLIC 20 mg, comprimé pelliculéROCHE REGISTRATION (ALLEMAGNE)
- IrelandCotellic 20 mg film-coated tabletsRoche Registration GmbH
- BelgiumCotellic 20 mgRoche Registration
- NetherlandsCotellic 20 mg filmomhulde tablettenRoche Registration Ltd.
- PolandCotellicRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cotellic
- Liechtenstein · Cotellic
- Norway · Cotellic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2de39cbe-0309-4b02-a6ef-86b6f9c2ce93 GET /v1/drugs/2de39cbe-0309-4b02-a6ef-86b6f9c2ce93?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "cobimetinibum 20 mg",
"valid_from": "2026-09-01",
"limitations": "[{\"description\":\"<!DOCTYPE html>\\n<html>\\n<head></head>\\n<body>\\n<p>In Kombination mit ZELBORAF zur Behandlung von Patienten mit nicht resezierbarem oder metastasiertem Melanom mit BRAF-V600-Mutation. Nur bis zur Progression der Krankheit.<br>Die Behandlung bedarf der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.<br><br>Die Roche Pharma (Schweiz) AG vergütet nach Aufforderung durch denjenigen Krankenversicherer, bei dem die versicherte Person zum Zeitpunkt des Bezugs versichert war, auf die Kombination von ZELBORAF und COTELLIC dem Krankenversicherer für jede bezogene COTELLIC Packung (=Indikator für einen Behandlungszyklus) <strong>35.03%</strong> des Fabrikabgabepreises jeder COTELLIC Packung zurück. Die Mehrwertsteuer kann nicht zusätzlich zu diesem Anteil des Fabrikabgabepreises zurückgefordert werden.<br><br>Der Indikationscode dieser Limitierung ist an den Krankenversicherer zu übermitteln.</p>\\n</body>\\n</html>\",\"costApproval\":null,\"indication\":\"20417.01\",\"isNew\":true,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-09-01\",\"validTo\":\"2029-08-31\"}]",
"galenic_form": "Filmtabl 20 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2016-05-01",
"self_retention_pct": 10
}See everything about cobimetinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.